FindTrial
Sign In

Use of ultrasound to measure stomach volume in patients who take a carbohydrate drink versus fully fasted patients before surgery.

Comparison of Ultrasound-Measured Gastric Residual Volume in Fasted and Malt-dextrin Fed Colorectal Cancer Patients: Randomised Controlled Trial [GARV] - GaRV

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/053238
Enrollment
150
Registered
2023-05-30
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Maltdextrin drink (Carboload): The patients randomised in Group C will receive 800 ml Carboload feeding at around 10 PM the night before surgery and further 400 mL Carboload at around 6

Sponsors

Tata Medical Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who will require general anaesthesia for abdominal surgeries for colorectal cancer. Patients posted as first case of the day.

Exclusion criteria

Exclusion criteria: History of gastro esophageal reflux disease (GERD) Known case of ventral hernia Patient with intestinal obstruction Patient posted for emergency surgery BMI >30 Ongoing steroid treatment Diabetic Patients Patients with naso-gastric/ naso-jejunal tubes in-situ.

Design outcomes

Primary

MeasureTime frame
The primary outcome to be measured in the study will be the RGV (in mL) measured with ultrasound.Timepoint: Just before induction of anaesthesia.—

Secondary

MeasureTime frame
Capillary Blood GlucoseTimepoint: After induction of anaesthesia—

Countries

India

Contacts

Public ContactArunangshu Chakraborty

Tata Medical Center

dr.arunangshu@gmail.com8910324933

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026